SCHEMBL24618092

SCHEMBL24618092

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)C4(c6ccc(-c7cccc(-c8nc(-c9ccccc9)nc(-c9ccccc9)n8)c7)cc6-5)C5CC6CC(C5)CC4C6)cc3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 3/20 0.37
KDM4E B2RXH2 2/20 0.36
LMNA P02545 2/20 0.36
GLA P06280 1/20 0.36
GP6 Q9HCN6 1/20 0.35
HTT P42858 1/20 0.34
HSD11B1 P28845 1/20 0.34
RARA P10276 1/20 0.33
RARB P10826 1/20 0.33
RARG P13631 1/20 0.33
PDK2 Q15119 3/20 0.33
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NTSR1 P30989 1/20 0.31
TDP2 O95551 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24618133 0.99 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24618131 0.99 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24618465 0.99 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24618023 0.98 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24618025 0.98 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL23177457 0.97 MEN1 (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24618074 0.96 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24608821 0.95 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24618230 0.95 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24618040 0.95 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223796-A1 ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223796-A1 ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE EXOC1, EXOC4, CHRM1 MEN1 2565/4885KMT2A 1796/4885ALDH1A1 1115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.